Roche Holding AG

ROG
Delayed Swiss Exchange - 01/23 05:31:37 pm
327.4CHF
-0.91%
Prev.330.4000
Open329.7500
High331.3500
Low326.8000
Volume1 876 967
Financials
Sales 2019 61 791 M
EBIT 2019 22 690 M
Net income 2019 14 074 M
Debt 2019 3 220 M
Yield 2019 2,83%
P/E ratio 2019 20,3x
P/E ratio 2020 19,5x
EV / Sales2019 4,58x
EV / Sales2020 4,42x
Capitalization 280 B
Company
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists...
Sector :
Pharmaceuticals - NEC
Calendar :
2020-01-30 Earnings Release
Trading Rating :
Investor Rating :
Latest news
01/23REMINDER : Invitation to Roche's Full Year Results 2019 Presentation
PU
01/23GENENTECH : 's Risdiplam Meets Primary Endpoint in Pivotal FIREFISH Trial in Infants With Type 1 Spinal Muscular Atrophy
BU
01/23Roche's Risdiplam meets primary endpoint in pivotal FIREFISH trial in infants with type 1 spinal muscular atrophy
GL
01/22Major companies join new alliance to accelerate transition to electric vehicles
AQ
01/22Roche wins approval for cancer drug Kadcyla in fast-growing China market
RE
01/22CHUGAI PHARMACEUTICAL : Notice of Stock Split and Partial Amendment to the Articles of Incorporation
AQ
01/22SEATTLE GENETICS : Achieves Milestone Following European Commission Approval of Roche's Polivy
AQ
01/21Health Care Up as Investors Seek Sectors Less Vulnerable to Virus Scare -- Health Care Roundup
DJ
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance330330328
Spread/Res.-0,91%-0,91%-0,17%
Spread/Supp.3,2%8,9%13%
Support317301289